Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

GM Bacterium Helps Destroy Advanced Tumors in Mice

29.11.2001


Generally speaking, we go to great lengths to rid our bodies of foreign bacteria, whether it’s by brushing our teeth, washing our hands or taking antibiotics. But new research suggests that when it comes to treating tumors, we may one day invite the bugs in. According to a study published yesterday in the early online edition of the Proceedings of the National Academy of Sciences, a bacterium that normally resides in soil, dust and dead flesh quickly destroys large tumors in mice when injected along with chemotherapy drugs.



Current cancer treatments are limited in part by their inability to destroy poorly vascularized areas of tumors: radiation requires oxygen to kill cells and chemotherapy drugs demand a blood system to reach their target. Anaerobic bacteria, on the other hand, actually prefer oxygen-free, or hypoxic, environments. Researchers have thus wondered for some time whether such bacteria might prove useful in combating tumors. Now Bert Vogelstein of Johns Hopkins University and his colleagues have shown that they can be. "The idea is to selectively attack these tumors from inside with the bacteria and from the outside with chemotherapy," Vogelstein explains. The team genetically engineered the bacterium Clostridium novyi, producing a toxin-free strain that, when administered with conventional drugs, eliminated nearly half of the advanced tumors in their lab mice within 24 hours. The healthy tissues surrounding the tumors, in contrast, remained intact.

The team’s so-called combination bacteriolytic therapy (COBALT) did have some negative outcomes, however. As many as 45 percent of the mice with the largest tumors died after treatment, presumably because of toxins released by the deteriorating tumor cells. "Any therapy which dramatically shrinks tumors may be subject to this side effect," the authors note. Yet although such tumor lysis is difficult to control in mice, it may be more easily controlled in humans. Still, whether or not COBALT will even work against human tumors at all remains to be seen. Says team member Kenneth Kinzler: "We hope that this research will add a new dimension to cancer treatment but realize that the way tumors respond to treatment in mice can be different than in humans."

Kate Wong | Scientific American
Further information:
http://www.sciam.com/news/112801/2.html

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

New materials: Growing polymer pelts

19.11.2018 | Materials Sciences

Earthquake researchers finalists for supercomputing prize

19.11.2018 | Information Technology

Controlling organ growth with light

19.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>